Candidemia in a Brazilian tertiary care hospital: Incidence, frequency of different species, risk factors and antifungal susceptibility;Candidemia em um hospital terciário brasileiro: Incidência, freqüência das diferentes espécies, fatores de risco e suscetibilidade aos antifúngicos

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 41, Issue 1, 2008, Pages 23-28

  França, João Cesar Beenke ^a,b   Ribeiro, Clea Elisa Lopes ^a   De Queiroz Telles, Flávio ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b NONE   (Brazil)

Author keywords

Azoles; Candida; Candidemia; Sepsis

Indexed keywords

AMPHOTERICIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETANERCEPT; FLUCONAZOLE; FLUCYTOSINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYCHLOROQUINE; INFLIXIMAB; ITRACONAZOLE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD FLOW; BRAZIL; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA PELLICULOSA; CANDIDA TROPICALIS; CANDIDEMIA; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; DOSE RESPONSE; DRUG SENSITIVITY; FEMALE; FUNGUS ISOLATION; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MALE; MORTALITY; OBSERVATIONAL STUDY; PARENTERAL NUTRITION; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; SCHOOL CHILD; SPECIES DIFFERENCE; TERTIARY HEALTH CARE; WARD;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; BRAZIL; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; FUNGEMIA; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS; SEX DISTRIBUTION;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; ISSATCHENKIA ORIENTALIS; PICHIA ANOMALA;

EID: 41549143267     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822008000100005     Document Type: Article

References (32)

1. Abi-Said D, Anaisse E, Uzun O, Raad I, Pinzcoaski H, Vartivarian S. The Epidemiology of Hematogenous Candidiasis by Different Candida Species. Clinical Infectious Diseases 24: 1122-1128, 1997.
2. Alonso-Valle H, Acha O, Garcia-Palomo JD, Farinas-Álvarez C, Fernandez-Mazarrasa C, Farinas MC. Candidemia in Terciary Care Hospital: Epidemiology and Factors Influencing Motality. European Clinical Microbiology Infectious Diseases 22: 254-257, 2003.
3. Antunes AGV, Pasqualotto AC, Diaz MC, Azevedo PA, Severo LC. Candidemia ia a Brazilian Terctiary Care Hospital: Species Distribution and Antifungal Susceptibility Patterns. Revista do Instituto de Medicina Tropical de São Paulo 46: 239-241, 2004.
4. Aquino VR, Lunardi WL, Goldmani LZ, Barth AL. Prevalence, Susceptibility Profififile for Fluconazole and Risk Factors for Candidemia in a Tertiary Hospital in Southern Brazil. The Brazilian Journal of Infectious Diseases 9: 411-418, 2005.
5. Becke-Sague CM, Jarvis WR, and The National Nosocomial Infections Surveillance System. Secular Trends in The Epidemiology of Nosocomial Infections in The Unit States, 1980-1990. Journal Infectious Diseases 167: 1247-1251, 1993.
6. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of Nosocomial Candidemia on Outcomes of Critically ill Patients. The American Journal of Medicine 113: 480-485, 2002.
7. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Fraustom S, Rinaldi MG, Saiman L, WEiblin RT, Wenzel RP. Risk Factors for Candidal Blood Stream Infections in Surgical Intensive Care Unit Patients. The Nemis Prospective Multicenter Risk Factors for Candidal Bloodstrean Infections in Surgical intensive Care Unit Study. Clinical Infectious Diseases 33: 177, 2001.
8. Clark TA, Hajjeh HA. Recent Trends in The Epidemiology of Invasive Mycoses. Current Opinion in Infectious Diseases 15: 569-574, 2002.
9. Colombo AL. Epidemiology and Treatment of Hematogenous Candidiasis. A Brazilian Perspective. The Brazilian Journal of Infectious Diseases 4: 113-118, 2000.
10. Colombo AL, Guimarães T. Epidemiology of Hematogenous Infections due to Candida spp. Revista da Sociedade Brasileira de Medicina Tropical 36: 599-607, 2003.
11. Colombo AL, Nucci M, Park BJ, Nouer SA, Arthington-Skaggs B, Matta DA, Warnock D, Morgan J, Brazilian Network Candidemia Study. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. Journal of Clinical Microbiology 44: 2816-2823, 2006.
12. Edmond MB, Wallace SE, McClish DK, Phaller MA, Jones RN, Wenzel RP. Nosocomial Bloodstream Infections in United States Hospitals: A Three-Year Analysis. Clinical Infectious Diseases 29: 239-244, 1999.
13. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida Species Infections in Critically ill Non-imunosuppresed Patients. The Lancet Infectious Diseases 3: 685-702, 2003.
14. Hadley S, Lee WW, Ruthazer R, Nasraway SA. Candidemia as a Cause and Multiple Organ Failure in Non-imunocompromised Patients. Critical Care Medicine 30: 1808-1814, 2002.
15. Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skggs BA, Mirza SA, Phelan M, Morgan J, Lee-Yang W, Ciblak MA, Benjamin LE, Sanza LT, Huie S, Yeo SF, Brandt ME, Warnock DW. Incidence of Bloodstream Infectious Due to Candida Species and in vitro Susceptibilities of Isolates Collected from 1998-2000 in a Population-Based Active Surveillance Program. Journal of Clinical Microbiology 2: 1519-1527, 2004.
16. Hazen KC, Baron EJ, Colombo AL, Girmenia C, Sanches-Souza A, Palacio A, Bedout C, Gibbs DL. Comparison of Susceptibility of Candida spp. To Fluconazole and Voriconazole in a 4-Yara Global Evaluation Using Disk Diffusion. Journal of Clinical Microbiology 41: 5623-5632, 2003.
17. Jarvis WR. Epidemiology of Nosocomial Fungal Infections with Enphasis on Candida Species. Clinical Infectious Diseases 20: 1526-1530, 1995.
18. Karlowsky JA, Zhanel GG, Klym KA, Hoban DJ, Kabani AM. Candidemia in a Canadian Tertiary Care Hospital from 1976 to 1996. Diagnostic Microbiology Infectious Diseases 28: 5-9, 1997.
19. Lockart SR, Joly S, Vargas K, Swails-Wenger J, Enger L, Soll DR. Natural Defenses Against Colonization Breakdown in the Oral Cavities of the Elderly Journal of Dental Research 78: 857-868, 1999.
20. Luzzati R, Amalfitano G, Lazzarini L, Soldani F, Bellino S, Solbiati M, Danzi MC, Vento S, Todeschini G, Vivenza C, Concia E. Nosocomial Candidemia in Non-Neutropenic Patients at an Italian Tertiary Care Hospital. European Journal Microbiology Infectious Diseases 19: 602-607, 2000.
21. Martin GS, Mannino DM, Eaton S, Moss M. The Epidemiology of Sepsis in The United States from 1979 through 2000. The New England Journal of Medicine 348: 1546-1554, 2003.
22. Nguyen MH, Peacock LE, Morris AJ, Tanner DC, Nguyen ML, Snydman DR, Wagner MM, Rinaldi MG, Yu VL. The Changing Face of Candidemia: Emergence of Non-Candida albicans Species and Antifungal Resistance. The American Journal of Medicine 100: 617-623, 1996.
23. Nucci M, Colombo AL. Risk Factors for Breakthrough Candidemia. European journal Microbiology Infectious Diseases 21: 209-211, 2002.
24. Nucci M, Silveira MI, Spector N, Silveira F, Velasco E, Akiti T, Barreiros G, Derossi A, Colombo AL, Pulcheri W. Risk Factors for Death Among Cancer Patients with Fungemia. Clinical Infectious Diseases 27: 107-111, 1998.
25. Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological Factors Influencing of Nosocomial Bloodstream Infections: A 6-Year Validated, Population-Based Model Clinical Infectious Diseases 24: 1068-1078, 1997.
26. Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, Kauffman CA, Hyslop N, Mangino JE, Chapman S, Horowitz HW, Edwards JE, Dismukes WE. For The NIAID Mycoses Study Group. A Prospective Obsrvational Study of Candidemia. Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients. Clinical Infectious Diseases 37: 634-643, 2003.
27. Phaller MA, Diekma DJ, Messer SA, Boyken L, Hollis RJ. Activities of Fluconazole and Voriconazole against 1586 Recent Clinical Isolates of Candida Species Detrmined by Broth Microdilution, Disk Diffusion, and Etest Methods: Report from The ARTEMIS global Antifungal Susceptibility Program, 2001. Journal of Clinical Microbiology 41: 1440-1446, 2003.
28. Phaller MA, Messer SA, Hollis RJ, Jones RN, Diekma DJ. In vitro of Ravuconazole and Voriconazole Comoared with Those Of Four Approved Systemic Antifungal Agents against 6970 Clinical Isolates of Candida spp. Antimicrobial Agentes and Chemotherapy 46: 1723-1727, 2002.
29. Pasqualotto AC, Nedel WL, Machado TS, Severo LC. A 9-year Study Comparing Risk Factors and the outcome of Pediatrics and Adults with Nosocomial Candidemia. Mycopathologia 160: 111-116, 2005.
30. Viscoli C, Girmenia C, Marinus A, Collette L, Martino P, Vandercam B, Doyen C, Lebeau B, Spence D, Kremery V, Pauw B, Meunier F, and the Invasive Fungal Group of the EORTC. Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatmment of Cancer (EORTC). Clinical Infectious Diseases 28: 1071-1079, 1999.
31. Viudes A, Peman J, Canton E, Úbeda P, Lopez-Ribot JL, Gobernado M. Candidemia at a Terciary-Care Hospital: Epidemiology, Treatment, Clinical Outcome and Risk Factors for Death. European Journal of Microbiology Infectious Diseases 21:767-774, 2002.
32. Wingard JR. Importance of Candida species other than Candida albicans as pathogens in oncology patients. Clinical Infectious Diseases 20: 115-125, 1995.